Examining PARP Inhibitors in the Maintenance Setting of Ovarian Cancer
February 13th 2018PARP inhibitors have drastically changed the treatment landscape – and outcomes – of patients with ovarian cancer. However, despite promise shown among this class of drugs, it is still unclear which agent is the best to use in the maintenance setting.
Zika Virus Explored for Brain Cancer Treatment
September 19th 2017In early 2015, Zika outbreaks caused widespread panic in many parts of North and South America. However, now researchers are exploring the possibility of putting the virus to good use: fighting glioblastoma multiforme (GBM), the most deadly type of brain cancer.
Increased Abdominal Fat Associated With Higher Cancer Risk
September 12th 2017A higher percentage of body fat – specifically fat in the abdominal area – was associated with an increased risk of certain cancers for postmenopausal women, according to a recent study presented at the 2017 European Society of Medical Oncology (ESMO) Congress in Madrid, Spain.
BRCA Gene Mutation May Harm Fertility Preservation in Women With Breast Cancer
September 10th 2017Women with breast cancer who are positive for the BRCA gene mutation may be more likely to encounter difficulty with fertility preservation compared to women with breast cancer who have tested negative for the BRCA mutation.
Careers of Young Survivors Can be Disrupted by Late-Emerging Side Effects of Cancer Treatment
September 9th 2017Side effects that arise months or years after adolescents and young adults (AYAs) have completed cancer treatment — known as late effects — can significantly affect both careers and quality of life in this population.
Multiple Myeloma Survivor Takes on the Boston Marathon
July 25th 2017"I wanted to go do it the best I could, considering all the physical limitations. I just wanted to start, and I wanted to finish the Boston Marathon. The notion of time was not in the equation." — JEFF GOAD, multiple myeloma survivor